In the diabetes prevention program outcomes study dppos, type 2 diabetes was not associated with cognition, although higher hba1c was related to decreased cognitive function after adjusting for. The diabetes prevention program outcomes study dppos is a longterm followup of the dpp to investigate whether the delay in development of diabetes seen during the dpp can be sustained and to assess longterm effects of the interventions on health. The national diabetes prevention program ndpp is a widely disseminated translation of the highly successful lifestyle change intervention from the diabetes prevention program research study 5,6. Request pdf longterm weight loss with metformin or lifestyle intervention in the diabetes prevention program outcomes study. Using a reaim framework to identify promising practices. Longterm effects of lifestyle intervention or metformin on. The dpp was conducted in a cohort at high risk for the development of diabetes on the basis of.
The cdc developed the national diabetes prevention program ndpp, a publicprivate partnership working to offer evidencebased, costeffective interventions across the us with the goals of reducing the growing problem of prediabetes and type 2 dm as well as to build on the dpp trial. Limited competition for the continuation of the diabetes prevention program outcomes study. This studys objective was to examine clinical outcomes up to 3 years postbaseline and the relationship. Case reports on diabetesrelated outcomes for pregnant women. Type 2 diabetes is a major public health problem in australia with prevalence increasing in parallel with increasing obesity. The national diabetes prevention program national dpp is a partnership of public and private organizations working to prevent or delay type 2 diabetes. To allow nih to identify a group of applications as a related set of collaborative applications, the titles for each application in the set must have the following format. The diabetes prevention program dpp 1 showed that intensive lifestyle intervention and metformin administration reduced diabetes incidence compared with placebotreated control subjects. The protocol for the diabetes prevention program outcomes study dppos, describes the background, design and organization of the dppos. Diabetes prevention program outcomes study dppos niddk. Type 2 diabetes prevention evidence summary randomized clinical control trials. Most in the diabetes prevention program and diabetes prevention program outcomes study. Power up for healthparticipants perspectives on an adaptation of the national diabetes prevention program to. Longterm safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study the diabetes prevention program research group diabetes care apr 2012, 35 4 731737.
Diabetes prevention program outcomes study full text view. National diabetes education program ndep 19882019 working with local and national partners, ndep sought to improve the treatment and outcomes for people with diabetes, promote early diagnosis, and prevent or delay the onset of type 2 diabetes. The diabetes prevention program dpp, funded by the national institute of diabetes and digestive and kidney diseases niddk and conducted at 25 centers nationwide, was a landmark trial to show that lifestyle changes or metformin can effectively delay diabetes in a diverse population of overweight or obese american adults at high risk of diabetes in the short term and long term compared to. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. This foa invites collaborative u01 cooperative agreement applications from the diabetes prevention program outcomes study dppos biostatistics research center brc to undertake continued followup of the dppos cohort.
Diabetes prevention program outcomes study phase 1 data release october 2011 4 of 22 1. Reduction in the incidence of type 2 diabetes with lifestyle. The dppos was designed to examine the longerterm impact of the original treatment interventions. Factors affecting the decline in incidence of diabetes in.
Diabetes prevention program outcomes study study documents go back to all study documents index of forms. The diabetes prevention program dpp was a major clinical trial. Lipid profile was measured annually, with statin treatment determined by a participants own physician. The niddksponsored diabetes prevention program dpp and ongoing dpp outcomes study dppos are major studies that changed the way people approach type 2 diabetes prevention worldwide. Research design and methods during the diabetes prevention program outcomes study n3234, the longterm followup to a randomized clinical trial of interventions to prevent t2dm, incident diabetes was assessed by annual 75 g oral glucose tolerance testing and semiannual fasting glucose. The longterm followup study of the dpp, entitled the diabetes prevention program outcomes study dppos, 20022015, was designed to take further advantage of the version 4.
Metformin and type 2 diabetes prevention diabetes spectrum. The longterm followup study of the dpp, entitled the diabetes prevention program outcomes study dppos, 20022015, was designed to take further advantage of the scientifically and clinically valuable cohort of dpp volunteers and the large volume of data. Jun 05, 2002 diabetes prevention program research group. The dppos study sought to evaluate the effects of the interventions on the further development of diabetes and diabetes complications, including retinopathy, microangiopathy, and cardiovascular disease. Evaluation of a digital diabetes prevention program. Its outcomes study dppos observed patients after the masked treatment phase ended. Over the entire study, the cumulative incidence was 27% lower for the lifestyle group than for the placebo group p study of the dpp, entitled the diabetes prevention program outcomes study dppos, 20022015, was designed to take further advantage of the version 4.
Engagement and outcomes in a digital diabetes prevention. Longterm weight loss with metformin or lifestyle intervention in. Diabetes prevention program outcomes study full text. The diabetes prevention program dpp showed that intensive lifestyle intervention and metformin administration reduced diabetes incidence compared with placebotreated control subjects. Diabetes prevention program outcomes study data release. The diabetes prevention program dppa major clinical trial involving 3,234 people with impaired glucose tolerance, a condition that often precedes diabetes demonstrated that some people at high risk for type 2 diabetes can prevent or delay the onset of the disease by losing 5 percent to 7 percent of their body weight and getting 30. Longterm safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study. Realmuto l, kamler a, weiss l, garywebb tl, hodge me, pagan ja, et al. The diabetes prevention program outcomes study dppos is the longterm followup of the original dpp study. At the end of the 3 years of active intervention, the dpp was closed and was converted to a longterm followup study, the dpp outcomes study dppos, to. The largest and longest clinical trial of metformin for the prevention of diabetes is the diabetes prevention program diabetes prevention program outcomes study dppdppos. The followup study, the diabetes prevention program outcomes study dppos, was initiated in 2002 to measure the longterm effects of interventions used in the dpp study on the development of type 2 diabetes and associated complications. Diabetes prevention program outcomes study dppos highlights.
Over the entire study, the cumulative incidence was 27% lower for the lifestyle group than for the placebo group p diabetes, with 1. Longterm metformin use and vitamin b12 deficiency in the diabetes prevention program outcomes study vanita r. The diabetes prevention program dpp, funded by the national institute of diabetes and digestive and kidney diseases niddk and conducted at 25 centers nationwide, was a landmark trial to show that lifestyle changes or metformin can effectively delay diabetes in a diverse population of overweight or obese american adults at high risk of. Prevention is an essential component of strategies to reduce the diabetes burden. The 10year costeffectiveness of lifestyle intervention. In an observational analysis, we examined whether regression to ngr also reduced risk for microvascular disease mvd. Diabetes prevention program fact sheet national kidney. The national diabetes prevention program national dpp is rapidly expanding in an effort to help those at high risk of type 2 diabetes prevent or delay the disease. Regression from prediabetes to normal glucose regulation. The application submitted under this foa is linked to rfadk20501 which will support the dppos clinical centers.
The dpp showed that people who are at high risk for type 2 diabetes can prevent or delay the disease by losing a modest amount of weight through lifestyle changes dietary changes and increased physical activity. Dppos is by far the largest of the diabetes prevention studies with a cohort randomly assigned to metformin. The national diabetes prevention program lifestyle intervention curriculum is based on the curriculum from the diabetes prevention program dpp research study supported by the national institutes of health, national institute of diabetes and digestive and. Objective translations of the diabetes prevention program dpp have proliferated in recent years, with increasing expansion to digital formats.
Although these dpp translations have consistently shown favorable clinical outcomes, longterm data for digital formats are limited. Study protocol and statistical analysis plan pdf may 22, 2019. Factors affecting the decline in incidence of diabetes in the. The diabetes prevention program dpp 1 and its followup, the diabetes prevention program outcomes study dppos 2,3, have demonstrated the bene. In addition to providing extensive resources, the ndpp certifies programs providing diet and physical activity interventions based on the u. Research design and methods data on resource utilization, cost, and quality. Longterm metformin use and vitamin b12 deficiency in the. We report the 10year withintrial costeffectiveness of the interventions.
The national diabetes prevention program ndpp is a partnership between the cdc and private organizations working to reduce diabetes in the u. The followup cohort, the diabetes prevention program outcomes study dppos, is in its 15th year and has continued to ascertain incident diabetes as well as diabetes complications. During the first 7 years of the diabetes prevention program outcomes study dppos, diabetes incidence rates, when compared with the diabetes prevention program dpp, decreased in the placebo. Standardsofmedicalcareindiabetes 2020 abridged for. Longterm effects of lifestyle intervention or metformin.
The diabetes prevention program dpp was a randomized controlled trial which enrolled overweight and glucoseintolerant participants. The dpp enrolled participants over a 3year period ending june 1999, therefore participants had varying duration of dpp followup depending on their year of. The diabetes prevention program dpp was a major clinical trial, or research study, aimed at discovering whether either diet and exercise or the oral diabetes drug metformin glucophage could prevent or delay the onset of type 2 diabetes in people with impaired glucose tolerance igt. Evaluation of a digital diabetes prevention program adapted. Reduction in the incidence of type 2 diabetes with. The diabetes prevention program outcomes study dppos, the 10year followup study to. In the dppdppos, persons at high risk for type 2 diabetes have been continued on randomized metformin treatment for over 10 years. Infertility, gravidity, and risk of diabetes among high. Longterm effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15year followup. Conclusion overall, intensive lifestyle intervention achieved, with less medication, a comparable long. Nov 14, 2009 the diabetes prevention program outcomes study dppos is a longterm followup of the dpp to investigate whether the delay in development of diabetes seen during the dpp can be sustained and to assess longterm effects of the interventions on health. The protocol is maintained by the coordinating center coc at the george washington university biostatistics center through new releases of the entire protocol or issuance of supplemental protocol memoranda. Research design and methods generalized estimating. Diabetes prevention program outcomes study study documents.
Partners make it easier for people at risk for type 2 diabetes to participate in evidencebased lifestyle change programs to reduce their risk of type 2 diabetes. The diabetes prevention program research group thanks the participants of the diabetes prevention program and diabetes prevention program outcomes study for their commitment and dedication. Nov 27, 2019 the dpp used in this study achieved full recognition status from the centers for disease control and preventions diabetes prevention recognition program 21. The clinical intervention consists of a minimum of 16 intensive core sessions of a centers for disease control and prevention cdc approved curriculum furnished. Medicare diabetes prevention program mdpp expanded model. The diabetes prevention program dpp and dpp outcomes study dppos periods, and the overlap between them, are shown. Longterm effects of metformin on diabetes prevention.
Regression from prediabetes to normal glucose regulation and. The diabetes prevention program research group conducted a large, randomized clinical trial involving adults in the united states who were at high risk for the development of type 2 diabetes. In 2012, the centers for disease control and prevention funded six national organizations to scale and sustain multistate delivery of the national dpp lifestyle change intervention lci. Objective the diabetes prevention program dpp and its outcomes study dppos demonstrated that either intensive lifestyle intervention or metformin could prevent type 2 diabetes in highrisk adults for at least 10 years after randomization. At the end of the 3 years of active intervention, the dpp was closed and was converted to a longterm followup study, the dpp outcomes study dppos, to determine whether the. The medicare diabetes prevention program expanded model is a structured intervention with the goal of preventing type 2 diabetes in individuals with an indication of prediabetes. Objective regression from prediabetes to normal glucose regulation ngr was associated with reduced incidence of diabetes by 56% over 10 years in participants in the diabetes prevention program outcomes study dppos. Exploring residual risk for diabetes and microvascular. There is strong and consistent evidence from randomised controlled trials that type 2 diabetes can be prevented or delayed through lifestyle modification which improves diet, increases. Diabetes prevention program outcomes study the diabetes prevention program outcomes study dppos, the 10year followup study to the dpp, has closely followed 88 percent of the surviving dpp participants who were eligible to join. The dpp diabetes prevention program was a randomized controlled trial that compared weight loss with metformin, intensive lifestyle intervention ils, or placebo. The diabetes prevention program dppdpp outcomes study dppos represents one of the largest and longest studies of metformin treatment.
1392 147 1497 1471 1062 1436 1020 1138 1071 905 116 215 229 1020 1106 489 1078 399 703 326 381 1049 693 1477 550 1133 734 603 503 281 732 1371 1379 798 1158 203